Sino Biopharmaceutical Limited (HKG:1177)
7.04
-0.05 (-0.71%)
Oct 28, 2025, 4:08 PM HKT
Sino Biopharmaceutical Market Cap
Sino Biopharmaceutical has a market cap or net worth of 125.85 billion as of October 29, 2025. Its market cap has increased by 67.38% in one year.
Market Cap
125.85B
Enterprise Value
130.82B
Revenue
33.49B
Ranking
n/a
PE Ratio
29.84
Stock Price
7.04
Market Cap Chart
Since September 29, 2000, Sino Biopharmaceutical's market cap has increased from 329.97M to 125.85B, an increase of 38,040.10%. That is a compound annual growth rate of 26.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 125.85B | 116.03% |
| Dec 31, 2024 | 58.26B | -8.75% |
| Dec 29, 2023 | 63.85B | -24.41% |
| Dec 30, 2022 | 84.46B | -17.53% |
| Dec 31, 2021 | 102.41B | -27.33% |
| Dec 31, 2020 | 140.92B | 3.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 265.86B |
| Hansoh Pharmaceutical Group Company | 210.56B |
| JD Health International | 200.09B |
| WuXi Biologics | 147.39B |
| Innovent Biologics | 146.59B |
| Akeso | 106.12B |
| Sichuan Kelun-Biotech Biopharmaceutical | 102.04B |
| Alibaba Health Information Technology | 95.40B |